next-generation cell therapy manufacturing platform
Sarcura has raised €7.0M across 1 funding round from 7 investors, most recently a Seed round in Nov 2022. Based in Klosterneuburg, Austria; active in Deeptech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-18 | Seed | €7.0M |
| Axilium Holding,HCVC,IST cube,Lansdowne Partners,Nina Capital,Novacapital+1 more |
| View deal → |
